Topic Schering Plough

News Schering Plough

• Bausch + Lomb Names Daniel M. Wechsler as Global President, Pharmaceuticals

  Bausch + Lomb has named Daniel M. Wechsler as corporate vice president and global president of its Pharmaceuticals business. Mr. Wechsler was most recently head of U.S. Strategy, Commercial Model Innovation and Business Development for Merck & Co., a role to which he was appointed following the com more

• Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors

  Regenicin, Inc., a clinical-stage biotechnology company, announced that Dr. Joseph Rubinfeld, one of the four original founders of Amgen, Inc., has agreed to join the company's board of directors. Dr. Rubinfeld will be instrumental to assisting the compan's commercialization efforts of PermaDerm(TM) more

• Pharming and Sanofi Chimie sign manufacturing agreement for the drug substance of Ruconest

  Pharming Group NV and Sanofi Chimie, wholly owned subsidiary of sanofi-aventis announced the signing of a toll manufacturing agreement to increase the production capacity of the drug substance of Ruconest(TM), which will improve RuconestTM cost of goods and competitiveness and will put Pharming in more

Publications Schering Plough

• Effect of dietary alginic acid on juvenile tilapia (Oreochromis niloticus) intestinal microbial balance, intestinal histology and growth performance

  The aim of the present study was to assess the effect of a commercial alginic acid source (Ergosan) on tilapia Oreochromis niloticus intestinal microbial balance, intestinal morphology, and growth parameters. Fish were fed a basal control diet or the basal diet plus a source of alginic acid (5 g kg- more

• Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas

  Temozolomide-based chemotherapy represents an incremental improvement in the treatment of patients with high-grade gliomas. Notwithstanding a survival benefit in a subset of patients with high-grade gliomas, temozolomide (TMZ; Temodar®, Schering-Plough Pharmaceuticals, NJ, USA) is the primarily pall more

• Determination of chlorpheniramine in human plasma by HPLC‐ESI‐MS/MS: application to a dexchlorpheniramine comparative bioavailability study

  In the present study a fast, sensitive and robust validated method to quantify chlorpheniramine in human plasma using brompheniramine as internal standard (IS) is described. The analyte and the IS were extracted from plasma by LLE (diethyl ether-dichloromethane, 80:20, v/v) and analyzed by HPLC-ESI- more

Market studies Schering Plough

• Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021

  What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to 2021. We predict and explain the commercial opportunities in that industry and market. Our report gives you revenue forecasts to 2021 for treat more

• World Biological Drugs Market 2011-2021

  Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. We provide original research, data and opinions to benefit your work now. What revenues will biopharmaceutical markets achieve fro more

• Leading Anti-Cancer Drugs: World Market Prospects 2011-2021

  What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now. What revenues will cancer treatment markets generate from 2011 to 2021 more

Websites Schering Plough